Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its structure allows for the modulation of biological activity in drug candidates targeting neurological disorders. Commonly employed in medicinal chemistry for constructing cyclobutane-based amine scaffolds that enhance metabolic stability and binding selectivity. Also utilized in the preparation of receptor ligands, especially for serotonin and dopamine receptors. Its bromoaryl group enables further functionalization via cross-coupling reactions, making it valuable in structure-activity relationship (SAR) studies.